Haridimos Kondylakis
1
* , PhD ;
Irene Alice Chicchi Giglioli
2
* , PhD ;
Dimitrios Katehakis
1
* , MSc ;
Hatice Aldemir
2
* , PhD ;
Paul Zikas
3
* , PhD ;
George Papagiannakis
1
* , PhD ;
Santiago Hors-Fraile
2
* , PhD ;
Pedro L González-Sanz
2
* , MD ;
Konstantinos Apostolakis
1
* , PhD ;
Constantine Stephanidis
1
* , Prof Dr ;
Francisco J Núñez-Benjumea
4
* , PhD ;
Rosa M Baños-Rivera
5
* , Prof Dr ;
Luis Fernandez-Luque
2
* , PhD ;
Angelina Kouroubali
1
* , PhD
1
FORTH-ICS, Heraklion, Greece
2
Adhera Therapeutics (United States), Wake Forest, CA, United States
3
ORamaVR SA, Heraklion, Greece
4
Innovation & Data Analysis Unit, Institute of Biomedicine of Seville, IBiS/Virgen Macarena University Hospital/CSIC/University of Seville, Seville, Spain
5
Polibienestar Institute, University of Valencia, Valencia, Spain
*all authors contributed equally